CIK 0001274737
- Non-accelerated filer
- Smaller reporting company
EXAGEN INC.
Sign in to watch- Ticker
- XGN
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 760-560-1501
- Business address
- 1261 LIBERTY WAY, VISTA, CA, 92081
- Former names
- EXAGEN DIAGNOSTICS INC
- 4 Exercise or conversion Chief Operating Officer acquired 1,934 shares (option exercise)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Chief Financial Officer acquired 37,500 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 37,500 shares (grant or award)
- 4 Grant or award President and CEO acquired 50,000 shares (grant or award)
- 4 Open-market sale Director sold 3,000 shares at $17.00 ($51,000)
- 4 Open-market sale 10% owner sold 51,667 shares at an average $16.04 ($828,607)
- 4 Open-market sale 10% owner sold 110,000 shares at an average $16.04 ($1,764,738)
- 4 Open-market sale Director sold 1,271 shares at an average $15.52 ($19,723)
- 4 Open-market sale Director sold 5,729 shares at an average $15.63 ($89,534)
- 4 Open-market sale 10% owner sold 15,000 shares at $16.04 ($240,584)
- 4 Open-market sale 10% owner sold 32,580 shares at an average $16.05 ($522,965)
- 4 Open-market sale 10% owner sold 125,000 shares at $12.00 ($1,500,563)
- 4 Open-market sale Director sold 12,000 shares at $12.23 ($146,726)
- 4 Open-market sale Director sold 17,500 shares at an average $13.60 ($238,075)
- 4 Open-market sale 10% owner sold 15,947 shares at an average $16.05 ($255,965)
- 4 Open-market sale Director sold 882 shares at $16.21 ($14,293)
- 4 Open-market sale Director sold 6,618 shares at an average $15.35 ($101,577)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
Page 6 of 9 · 168 filings